Business
Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand – CNBC
Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand CNBCLilly reports third-quarter 2026 financial…
